HER2 Amplification Has no Prognostic Value in Sporadic and Hereditary Ovarian Tumours

Whereas HER2 amplification is a well-known phenomenon in breast tumours, its frequency and clinical importance in ovarian cancer have not been established. The aim of the study was to compare the frequency of HER2 amplification in hereditary (BRCA-positive) and sporadic (BRCA-negative) ovarian tumou...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Brożek, Izabela, Kardaś, Iwona, Ochman, Karolina, Dębniak, Jarosław, Stukan, Maciej, Ratajska, Magdalena, Morzuch, Lucyna, Emerich, Janusz, Limon, Janusz
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2006
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3401919/
https://ncbi.nlm.nih.gov/pubmed/20223002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1897-4287-4-1-39
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados